Key result
Novel genetic variants in LIPA, IL5, TRIB1, and ABCG5/ABCG8 link to ~6% higher CAD risk per allele.
Case-Control (n=108,182)
Yes
Answers are grounded in this paper and cite their sources.
Coronary artery disease (CAD) has a significant genetic contribution that is incompletely characterized. To complement genome-wide association (GWA) studies, we conducted a large and systematic candidate gene study of CAD susceptibility, including analysis of many uncommon and functional variants. We examined 49,094 genetic variants in ∼2,100 genes of cardiovascular relevance, using a customised gene array in 15,596 CAD cases and 34,992 controls (11,202 cases and 30,733 controls of European descent; 4,394 cases and 4,259 controls of South Asian origin). We attempted to replicate putative novel associations in an additional 17,121 CAD cases and 40,473 controls. Potential mechanisms through which the novel variants could affect CAD risk were explored through association tests with vascular risk factors and gene expression. We confirmed associations of several previously known CAD susceptibility loci (eg, 9p21.3:p<10(-33); LPA:p<10(-19); 1p13.3:p<10(-17)) as well as three recently discovered loci (COL4A1/COL4A2, ZC3HC1, CYP17A1:p<5×10(-7)). However, we found essentially null results for most previously suggested CAD candidate genes. In our replication study of 24 promising common variants, we identified novel associations of variants in or near LIPA, IL5, TRIB1, and ABCG5/ABCG8, with per-allele odds ratios for CAD risk with each of the novel variants ranging from 1.06-1.09. Associations with variants at LIPA, TRIB1, and ABCG5/ABCG8 were supported by gene expression data or effects on lipid levels. Apart from the previously reported variants in LPA, none of the other ∼4,500 low frequency and functional variants showed a strong effect. Associations in South Asians did not differ appreciably from those in Europeans, except for 9p21.3 (per-allele odds ratio: 1.14 versus 1.27 respectively; P for heterogeneity = 0.003). This large-scale gene-centric analysis has identified several novel genes for CAD that relate to diverse biochemical and cellular functions and clarified the literature with regard to many previously suggested genes.
No takes yet. Share an insight, caveat, or question.
A 2011 study conducted a case-control in Coronary artery disease (n=108,182). 49,094 genetic variants in ~2,100 cardiovascular-related candidate genes (including novel variants near LIPA, IL5, TRIB1, and ABCG5/ABCG8) vs. Reference/non-risk alleles in controls was evaluated on Coronary artery disease susceptibility (OR 1.06-1.09). Novel genetic variants in or near LIPA, IL5, TRIB1, and ABCG5/ABCG8 were associated with increased coronary artery disease risk, with per-allele odds ratios ranging from 1.06 to 1.09.
Synapse has enriched 10 related papers. Consider them for comparative context: